Bio Preventive Medicine Corp. (TPEX:6810)

Market Cap	1.46B
Revenue	n/a
Net Income	n/a
Shares Out	49.45M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,339
Average Volume	42,050
Open	29.50
Previous Close	29.50
Day's Range	28.70 - 29.95
52-Week Range	21.90 - 36.15
Beta	-0.17
RSI	38.86
Earnings Date	n/a

About Bio Preventive Medicine

Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It provides DNlite test, a series of patented and clinically validated non-invasive urine test for diabetic kidney disease management, such as DNlite-IVD103 and DNlite-DN_Score. The company was founded in 2014 and is headquartered in Zhubei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6810